Mats Brännström is a professor at the University of Gothenburg and chairman of the Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sweden. ...

During the past decade, Mats Brännström conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mats Brännström" #1 collaborator was "Saint Joseph University, at Bellevue Medical Centre" with 1 trials as a collaborator and "The Swedish Research Council" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Mats Brännström" are "Mrk Anomaly" (2 trials), "Absolute Uterine Factor Infertility" (1 trials), "Infertility, Female" (1 trials), "Primary Uterine Infertility" (1 trials) and "Transplantation" (1 trials). Many other conditions were trialed in "Mats Brännström" in a lesser frequency.

Most popular intervention types in "Mats Brännström" are "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "uterine transplantation" (1 trials), "uterus transplantation" (1 trials) and "uterus transplantation surgery and IVF" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mats Brännström" are 3 trials for "Female" genders.

Currently, there are NaN active trials in "Mats Brännström". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 2 completed trials in Mats Brännström, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mats Brännström, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".